fda tirzepatide osa Obstructive sleep apnea with obesity: becomes the first approved medication option tirzepatide osa fda approval ZEPBOUND

doi: 10.2174/1381612827666210119104721 Epub ahead of print

GLP-1 receptor agonists are known to cause gastrointestinal issues , with nausea, vomiting, and diarrhea being the most commonly reported side effects

To sleep better on semaglutide, maintain a consistent sleep schedule, avoid large meals close to bedtime, stay hydrated, and ensure youre eating enough nutrients, especially protein

Its safe to use as part of your long-term wellness routine

Both albumin fusions extend the plasma half-lives of GLP-1 and FIX by manyfold 30,31,32,81,82

To dive deeper into managing these reactions, check out our side effects guide